Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 2,478 | 2,225 | 1,621 | 278.00 |
| Gross Profit | -2,478 | -2,225 | -1,621 | -278.00 |
| Selling General And Administration | 433,114 | 496,871 | 707,443 | 787,155 |
| General And Administrative Expense | 433,114 | 496,871 | 707,443 | 787,155 |
| Other Operating Expenses | 234,191 | 325,474 | 247,753 | 98,127 |
| Operating Expense | 667,305 | 822,345 | 955,196 | 885,282 |
| Operating Income | -669,783 | -824,570 | -956,817 | -885,560 |
| EBIT | -669,783 | -824,570 | -956,817 | -885,560 |
| Other Income Expense | -105,622 | 26,257 | -7,891 | -100,470 |
| Special Income Charges | -100,000 | -14,883 | -901.00 | -80,293 |
| Gain On Sale Of Security | -5,622 | 41,140 | -6,990 | -20,177 |
| Pretax Income | -775,405 | -798,313 | -964,708 | -986,030 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -775,405 | -798,313 | -964,708 | -986,030 |
| Net Income From Continuing Operation Net Minority Interest | -775,405 | -798,313 | -964,708 | -986,030 |
| Net Income Including Noncontrolling Interests | -775,405 | -798,313 | -964,708 | -986,030 |
| Net Income Common Stockholders | -775,405 | -798,313 | -964,708 | -986,030 |
| Net Income | -775,405 | -798,313 | -964,708 | -986,030 |
| EBITDA | -667,305 | -822,345 | -955,196 | -885,282 |
| Normalized EBITDA | -561,683 | -848,602 | -947,305 | -784,812 |
| Reconciled Depreciation | 2,478 | 2,225 | 1,621 | 278.00 |
| Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 |
| Basic Average Shares | 90.8M | 81.2M | 74.6M | 62.9M |
| Diluted Average Shares | 90.8M | 81.2M | 74.6M | 62.9M |
| Total Unusual Items | -105,622 | 26,257 | -7,891 | -100,470 |
| Total Unusual Items Excluding Goodwill | -105,622 | 26,257 | -7,891 | -100,470 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -669,783 | -824,570 | -956,817 | -885,560 |
| Diluted NI Availto Com Stockholders | -775,405 | -798,313 | -964,708 | -986,030 |
| Gain On Sale Of Ppe | -- | 0.00 | -901.00 | 0.00 |
| Impairment Of Capital Assets | 100,000 | 14,883 | 0.00 | 80,293 |
| Insurance And Claims | 12,340 | 14,309 | 19,422 | 16,099 |
| Net Income Continuous Operations | -775,405 | -798,313 | -964,708 | -986,030 |
| Other Gand A | 399,221 | 377,232 | 450,269 | 352,345 |
| Reconciled Cost Of Revenue | 2,478 | 2,225 | 1,621 | 278.00 |
| Salaries And Wages | 21,553 | 105,330 | 237,752 | 418,711 |
| Total Expenses | 669,783 | 824,570 | 956,817 | 885,560 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 12,424 | 344,208 | 639,856 | 338,511 |
| Cash Cash Equivalents And Short Term Investments | 14,136 | 346,079 | 645,886 | 352,697 |
| Cash Financial | 12,424 | 344,208 | 639,856 | 338,511 |
| Other Short Term Investments | 1,712 | 1,871 | 6,030 | 14,186 |
| Accounts Receivable | 0.00 | 1,359 | 8,604 | 45,318 |
| Receivables | 57,203 | 37,626 | 31,583 | 65,046 |
| Prepaid Assets | 9,313 | 24,381 | 16,376 | 30,841 |
| Current Assets | 80,652 | 408,086 | 693,845 | 448,584 |
| Gross PPE | 3.7M | 3.6M | 3.3M | 2.7M |
| Accumulated Depreciation | -22,684 | -17,027 | -11,678 | -12,670 |
| Net PPE | 3.7M | 3.6M | 3.3M | 2.7M |
| Total Non Current Assets | 3.7M | 3.6M | 3.3M | 2.7M |
| Total Assets | 3.7M | 4.0M | 4.0M | 3.1M |
| Accounts Payable | 1.1M | 574,618 | 319,313 | 241,290 |
| Payables | 1.1M | 574,618 | 319,313 | 241,290 |
| Payables And Accrued Expenses | 1.1M | 574,618 | 319,313 | 241,290 |
| Current Liabilities | 1.1M | 574,618 | 319,313 | 241,290 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 1.1M | 574,618 | 319,313 | 241,290 |
| Common Stock | 11.7M | 11.2M | 10.8M | 8.3M |
| Capital Stock | 11.7M | 11.2M | 10.8M | 8.3M |
| Additional Paid In Capital | 1.4M | 1.4M | 1.3M | 1.7M |
| Retained Earnings | -10.6M | -9.9M | -9.1M | -8.7M |
| Common Stock Equity | 2.7M | 3.5M | 3.7M | 2.9M |
| Stockholders Equity | 2.7M | 3.5M | 3.7M | 2.9M |
| Total Equity Gross Minority Interest | 2.7M | 3.5M | 3.7M | 2.9M |
| Total Capitalization | 2.7M | 3.5M | 3.7M | 2.9M |
| Net Tangible Assets | 2.7M | 3.5M | 3.7M | 2.9M |
| Tangible Book Value | 2.7M | 3.5M | 3.7M | 2.9M |
| Working Capital | -969,819 | -166,532 | 374,532 | 207,294 |
| Invested Capital | 2.7M | 3.5M | 3.7M | 2.9M |
| Share Issued | 90.8M | 90.8M | 80.8M | 66.4M |
| Ordinary Shares Number | 90.8M | 90.8M | 80.8M | 66.4M |
| Machinery Furniture Equipment | 12,636 | 11,305 | 10,875 | 3,332 |
| Other Equity Interest | 191,160 | 653,588 | 617,198 | 1.6M |
| Other Properties | -- | 5,581 | -- | -- |
| Properties | 3.7M | 3.6M | 3.3M | 2.7M |
| Taxes Receivable | 57,203 | 36,267 | 22,979 | 19,728 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -213,907 | -603,867 | -626,845 | -363,665 |
| Cash Flow From Continuing Operating Activities | -213,907 | -603,867 | -626,845 | -363,665 |
| Depreciation And Amortization | 2,478 | 2,225 | 1,621 | 278.00 |
| Depreciation Amortization Depletion | 2,478 | 2,225 | 1,621 | 278.00 |
| Stock Based Compensation | 21,553 | 105,330 | 237,752 | 418,711 |
| Change In Working Capital | 437,308 | 110,488 | 89,433 | 117,783 |
| Change In Receivables | -19,577 | -6,043 | 33,463 | -36,938 |
| Change In Payables And Accrued Expense | 441,817 | 124,536 | 41,505 | 156,912 |
| Capital Expenditure | -117,877 | -266,107 | -597,981 | -1.5M |
| Purchase Of PPE | -117,877 | -266,107 | -597,981 | -1.5M |
| Net PPE Purchase And Sale | -117,877 | -160,388 | -586,274 | -1.5M |
| Investing Cash Flow | -117,877 | -160,388 | -586,274 | -1.5M |
| Cash Flow From Continuing Investing Activities | -117,877 | -160,388 | -586,274 | -1.5M |
| Issuance Of Capital Stock | 0.00 | 468,607 | 1.1M | 491,704 |
| Net Common Stock Issuance | 0.00 | 468,607 | 1.1M | 491,704 |
| Financing Cash Flow | 0.00 | 468,607 | 1.5M | 491,704 |
| Cash Flow From Continuing Financing Activities | 0.00 | 468,607 | 1.5M | 491,704 |
| Changes In Cash | -331,784 | -295,648 | 301,345 | -1.3M |
| Beginning Cash Position | 344,208 | 639,856 | 338,511 | 1.7M |
| End Cash Position | 12,424 | 344,208 | 639,856 | 338,511 |
| Free Cash Flow | -331,784 | -869,974 | -1.2M | -1.8M |
| Asset Impairment Charge | 100,000 | 14,883 | 0.00 | 80,293 |
| Capital Expenditure Reported | -- | -260,096 | -590,438 | -- |
| Change In Prepaid Assets | 15,068 | -8,005 | 14,465 | -2,191 |
| Common Stock Issuance | 0.00 | 468,607 | 1.1M | 491,704 |
| Depreciation | 2,478 | 2,225 | 1,621 | 278.00 |
| Gain Loss On Sale Of PPE | 0.00 | -42,639 | 901.00 | 0.00 |
| Net Income From Continuing Operations | -775,405 | -798,313 | -964,708 | -986,030 |
| Operating Gains Losses | -- | -42,639 | 901.00 | -- |
| Proceeds From Stock Option Exercised | -- | 0.00 | 385,000 | 0.00 |
| Sale Of PPE | 0.00 | 105,719 | 11,707 | 0.00 |
| Unrealized Gain Loss On Investment Securities | 159.00 | 4,159 | 8,156 | 5,300 |